Location History:
- San Diego, CA (US) (1999 - 2011)
- Oakland, CA (US) (2017)
- Irvine, CA (US) (2002 - 2020)
Company Filing History:
18 out of 15,528 
8 out of 20 
7 out of 24 
Years Active: 1999-2020
Title: Daniele Piomelli: A Leader in Innovative Pharmaceutical Research
Introduction
Daniele Piomelli, based in Irvine, CA, is a renowned inventor with a significant contribution to the field of pharmaceutical research, holding a total of 25 patents. His work focuses on developing novel therapeutic strategies to address complex medical conditions.
Latest Patents
Among his most recent innovations, Piomelli has developed a patent for Piperazinyl methanone NAAA inhibitors, which involves compositions and methods that modulate the activity of N-acylethanolamine acid amidase. This research aims to provide treatments for various pathological states, including pain, inflammatory conditions, and neurodegenerative disorders. Another significant patent revolves around inhibitors of the fatty acid amide hydrolase (FAAH) enzyme, featuring improved oral bioavailability and their potential use as medicaments.
Career Highlights
Piomelli's distinguished career includes insightful roles at prestigious academic institutions such as the University of California and Università degli Studi di Parma. Through his research, he has made groundbreaking advancements in understanding and treating conditions related to the endocannabinoid system.
Collaborations
Throughout his career, Daniele Piomelli has collaborated with notable scientists such as Marco Mor and Giorgio Tarzia. These collaborations have fostered a vibrant exchange of ideas that have propelled forward the field of cannabinoid research and pharmacology.
Conclusion
Daniele Piomelli continues to be a pivotal figure in pharmaceutical innovation, with a commitment to developing effective treatments for serious health conditions. His extensive patent portfolio reflects his dedication to advancing medical science for the betterment of society.